Accellacare of Wilmington is a clinical research site located in Wilmington, North Carolina, United States 28401.
Crixeo Clinical Trials Trust Score: 19/100 (FAILING). This profile has not yet been claimed by the site owner.
Accellacare of Wilmington has participated in 13 clinical trials with 9 currently active.
Therapeutic areas: Non-cystic Fibrosis Bronchiectasis, Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction.
Sponsors: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA, Amgen, Hanmi Pharmaceutical Company Limited.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in North Carolina · View every site in Wilmington
Trust Score: 19/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Accellacare of Wilmington has a Crixeo Trust Score of 19/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Accellacare of Wilmington has 13 clinical trials on record, with 9 currently active. Their work covers Non-cystic Fibrosis Bronchiectasis, Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction.
Accellacare of Wilmington has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.